Top Markets
Coin of the day
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Rank in Stocks #16324
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with NestlΓ© Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in PΓ©rigny, France.
Share Price
$0.94180721
Market Cap
$22.26M
Change (1 day)
0.38%
Change (1 year)
-14.35%
Country
FR
Trade Valbiotis SA (ALVAL)

Category

Price of ALVAL with the market cap of B
Valbiotis SA Valbiotis SA
ALVAL
$0.94180721
Market Capitalization of Valbiotis SA(ALVAL)
Market Cap: $22.26M
As of July 2026 Valbiotis SA has a market cap of $22.26M. This makes Valbiotis SA the world's 16324th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Valbiotis SA from 2017 to 2026
ALVAL compared with Top 5 Most Popular stocks
Price of ALVAL Asset B Mkt. of B Results
Valbiotis SA Valbiotis SA
$217,002 $22.26M
$5.130T +23,040,964.32%
Valbiotis SA Valbiotis SA
$195,617 $22.26M
$4.624T +20,770,336.50%
Valbiotis SA Valbiotis SA
$183,933 $22.26M
$4.348T +19,529,650.77%
Valbiotis SA Valbiotis SA
$120,955 $22.26M
$2.859T +12,842,806.05%
Valbiotis SA Valbiotis SA
$112,616 $22.26M
$2.662T +11,957,316.93%